Provectus Biopharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $26.2M
Liabilities Breakdown FY2014
Total Liabilities: $994.3K
Asset Breakdown
Total Assets: $26.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.4M | 66.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $92.2K | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.6M | 13.7% |
| Other Assets | $5.1M | 19.5% |
Liabilities Breakdown
Total Liabilities: $994.3K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $440.7K | 44.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $553.6K | 55.7% |